Burberry Shares Surge on Moncler Takeover Speculation Gold Prices Edge Higher on MCX as Dollar Weakens Amid USIran Peace Deal Speculation Barclays Raises Energy Transfer ET Price Target Citing Undervaluation Consumers Spend More in April Despite Elevated Gas Prices Latest Data Shows Gold and Silver Futures Extend Weakness as Breakdown Risk Persists AMD Commits 10 Billion to Taiwan AI Infrastructure for Advanced Chip Development BDX Q1 2026 Earnings EPS Surpasses Estimates with 347 Beat HMR Q1 2026 Earnings EPS Beats Estimates by Over 1000 but Stock Tumbles 20 Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity SRFM Q1 2026 Earnings EPS Beats Estimate by 263 as Revenue Remains Undisclosed GLMD Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges Telomir Pharmaceuticals TELO Consolidates Near 129 as Support and Resistance Levels Tighten Axalta Coating Systems Edges Higher as Shares Test Key Resistance Zone Brookfield Renewable Partners BEP Holds Steady as Renewable Energy Sector Faces Mixed Signals CelSci Corporation CVM Slips 078 as Shares Test Key Support Near 133 Pool Corporation POOL Rises 113 Approaches Key Resistance as Sector Sentiment Shifts UK Scorches on Hottest Day of 2026 as Bank Holiday Travel Disruptions Mount TSLA Q1 2026 Earnings EPS Beats Estimates by 867 as Stock Rises 178 Alchemy Investments Warrants ALCYW Hold Steady at 009 Amid Negligible Volume Diversified Energy Company Q2 2024 Earnings EPS Beats Estimates by Wide Margin as Operational Discipline Pays Off Smart Share Global EM Q2 2024 Earnings Stellar EPS Beat Surges 42957 Above Estimates Acadian Asset Management Inc AAMI Q1 2026 Earnings Strong EPS Beat Signals Resilience in Volatile Markets Sunstone Hotel Investors Inc SHO Q1 2026 Earnings EPS Surges Past Estimates Despite Flat Revenue Disclosure VTEX Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Revenue Uncertainty BFRI Q1 2026 Earnings Significant EPS Miss Yet Stock Rises on Operating Discipline SLDB Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline